Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertilsson L., Dengler H. J., Eichelbaum M., Schulz H. U. Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine. Eur J Clin Pharmacol. 1980 Feb;17(2):153–155. doi: 10.1007/BF00562624. [DOI] [PubMed] [Google Scholar]
- Bertilsson L., Eichelbaum M., Mellström B., Säwe J., Schulz H. U., Sjöqvist F. Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. Life Sci. 1980 Nov 3;27(18):1673–1677. doi: 10.1016/0024-3205(80)90642-6. [DOI] [PubMed] [Google Scholar]
- Challiner M. R., Park B. K., Odum J., Orton T. C., Parker G. L. The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus). Biochem Pharmacol. 1980 Dec;29(24):3319–3324. doi: 10.1016/0006-2952(80)90310-x. [DOI] [PubMed] [Google Scholar]
- Challiner M., Park B. K., Odum J., Orton T. C. The effect of 3-methylcholanthrene on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus). Biochem Pharmacol. 1981 Aug 1;30(15):2131–2134. doi: 10.1016/0006-2952(81)90233-1. [DOI] [PubMed] [Google Scholar]
- Danhof M., Idle J. R., Teunissen M. W., Sloan T. P., Breimer D. D., Smith R. L. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation. Pharmacology. 1981;22(6):349–358. doi: 10.1159/000137515. [DOI] [PubMed] [Google Scholar]
- Dengler H. J., Eichelbaum M. Polymorphismen und Defekte des Arzneimittelstoffwechesels als Ursache toxischer Reaktionen. Arzneimittelforschung. 1977;27(96):1836–1844. [PubMed] [Google Scholar]
- Eichelbaum M., Spannbrucker N., Steincke B., Dengler H. J. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol. 1979 Sep;16(3):183–187. doi: 10.1007/BF00562059. [DOI] [PubMed] [Google Scholar]
- FRANTZ A. G., KATZ F. H., JAILER J. W. 6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine. J Clin Endocrinol Metab. 1961 Oct;21:1290–1303. doi: 10.1210/jcem-21-10-1290. [DOI] [PubMed] [Google Scholar]
- Inaba T., Otton S. V., Kalow W. Deficient metabolism of debrisoquine and sparteine. Clin Pharmacol Ther. 1980 Apr;27(4):547–549. doi: 10.1038/clpt.1980.77. [DOI] [PubMed] [Google Scholar]
- Mahgoub A., Idle J. R., Dring L. G., Lancaster R., Smith R. L. Polymorphic hydroxylation of Debrisoquine in man. Lancet. 1977 Sep 17;2(8038):584–586. doi: 10.1016/s0140-6736(77)91430-1. [DOI] [PubMed] [Google Scholar]
- Ohnhaus E. E., Park B. K. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol. 1979 Mar 26;15(2):139–145. doi: 10.1007/BF00609878. [DOI] [PubMed] [Google Scholar]
- Park B. K. A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine. J Steroid Biochem. 1978 Oct;9(10):963–966. doi: 10.1016/0022-4731(78)90058-4. [DOI] [PubMed] [Google Scholar]
- Park B. K. Assessment of urinary 6 beta-hydroxycortisol as an in vivo index of mixed-function oxygenase activity. Br J Clin Pharmacol. 1981 Aug;12(2):97–102. doi: 10.1111/j.1365-2125.1981.tb01186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanghvi A., Wight C., Parikh B., Desai H. Urinary 17-hydroxycorticosteroid determination with p-hydrazinobenzenesulfonic acid-phosphoric acid. Am J Clin Pathol. 1973 Nov;60(5):684–690. doi: 10.1093/ajcp/60.5.684. [DOI] [PubMed] [Google Scholar]